News Notification

MedStudy 2023-2024 Internal Medicine Board Review

2111 views Tags: CME ABIM

The MedStudy 2023–2024 Internal Medicine Board Review is a comprehensive study program designed to assist physicians in preparing for the American Board of Internal Medicine (ABIM) certification and recertification exams. This review focuses on core internal medicine concepts and clinical knowledge essential for the exam. The MedStudy Internal Medicine Board Review is a trusted resource for internists seeking to prepare effectively for their board exams, providing a thorough and flexible study experience.

Content Highlights:

  • In-Depth Video Lectures: High-quality video lectures presented by expert internists, covering a wide range of internal medicine topics including cardiology, pulmonology, gastroenterology, nephrology, and more
  • High-Yield Content: Emphasizes key concepts and exam-relevant material based on the ABIM exam blueprint, ensuring a focused and efficient review
  • Flexible Learning: Videos and materials are accessible on various devices, allowing users to study at their own pace and convenience

MEDSTUDY 2023-2024 INTERNAL MEDICINE BOARD REVIEW

0 0 votes
Article Rating

MEDSTUDY 2023-2024 INTERNAL MEDICINE BOARD REVIEW TOPICS

CHECK SAMPLES

1. Acid-Base Disorders (25 minutes)

2. Allergy and Immunology (1 hour 25 minutes)

3. Cardiology (4 hours 14 minutes)

4. Dermatology (1 hour 37 minutes)

5. Endocrinology (3 hours 39 minutes)

6. Gastroenterology (3 hours 46 minutes)

7. General Internal Medicine (3 hours 43 minutes)

8. Hematology (2 hours 28 minutes)

9. Infectious Disease (3 hours 51 minutes)

10. Nephrology (3 hours 26 minutes)

11. Neurology (1 hour 45 minutes)

12. Oncology (1 hour 44 minutes)

13. Psychiatry (1 hour 43 minutes)

14. Pulmonary Medicine (4 hour 11 minutes)

15. Rheumatology (2 hours 47 minutes)

16. Statistics (38 minutes)

17. Question Preview (4 minutes)

18. Question Review (7 minutes)

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
error: Content is protected !!